Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Parallel Clinical Performance Study of the INSTI® and TruPlex Rapid Blood Typing Platforms

NCT07770360 is registered in ClinicalTrials.gov with bioLytical Laboratories as lead sponsor.

NCT NCT07770360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07770360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Parallel Clinical Performance Study of the INSTI® and TruPlex Rapid Blood Typing Platforms
Lead sponsor
bioLytical Laboratories
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
December 30, 2026
Enrollment
2,500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

abo blood type, rhd blood type